Exosome-based smart drug delivery tool for cancer theranostics R Kar, R Dhar, S Mukherjee, S Nag, S Gorai, N Mukerjee, D Mukherjee, ... ACS biomaterials science & engineering 9 (2), 577-594, 2023 | 87 | 2023 |
Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance S Hoque, R Dhar, R Kar, S Mukherjee, D Mukherjee, N Mukerjee, S Nag, ... Biomarkers 28 (2), 139-151, 2023 | 22 | 2023 |
Unlocking exosome-based theragnostic signatures: deciphering secrets of ovarian cancer metastasis S Mukherjee, S Nag, N Mukerjee, S Maitra, R Muthusamy, NK Fuloria, ... ACS omega 8 (40), 36614-36627, 2023 | 17 | 2023 |
Interrelation between extracellular vesicles miRNAs with chronic lung diseases R Dhar, S Mukherjee, N Mukerjee, D Mukherjee, A Devi, GM Ashraf, ... Journal of Cellular Physiology 237 (11), 4021-4036, 2022 | 15 | 2022 |
Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance S Mukherjee, R Dhar, S Jonnalagadda, S Gorai, S Nag, R Kar, ... Biomarkers 28 (6), 502-518, 2023 | 11 | 2023 |
Exosome DNA: an untold story of cancer. Clin Transl Disc 2023; 3: e218 B Bhattacharya, R Dhar, S Mukherjee | 6 | |
Role of exosomes in epithelial–mesenchymal transition B Bhattacharya, S Nag, S Mukherjee, M Kulkarni, P Chandane, D Mandal, ... ACS Applied Bio Materials 7 (1), 44-58, 2023 | 5 | 2023 |